Detection of ESBL among ampc producing enterobacteriaceae using inhibitor-based method

Pan African Medical Journal

Volumn 14, Issue , 2013, Pages

  Bakthavatchalu, Sasirekha ^a   Shakthivel, Uma ^a   Tannu, Mishra ^a  

^a JAIN UNIVERSITY   (India)

Author keywords

AmpC beta lactamases; Boronic acid; Cefepime; Enterobacteriaceae; ESBL

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE INHIBITOR; BORONIC ACID; CEFEPIME; CEFOTAXIME; CEFOXITIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG; AMPC BETA-LACTAMASES; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BORONIC ACID DERIVATIVE; CEPHALOSPORIN DERIVATIVE; AMPC BETA LACTAMASES;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISK DIFFUSION; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; INTERMETHOD COMPARISON; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; ANTAGONISTS AND INHIBITORS; ANTIBIOTIC RESISTANCE; BIOSYNTHESIS; BODY FLUID; COMPARATIVE STUDY; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTION; ENZYME INDUCTION; ENZYME SPECIFICITY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; RETRACTED ARTICLE; BORONIC ACID; DRUG ANTAGONISM; DRUG EFFECT;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASE INHIBITORS; BETA-LACTAMASES; BODY FLUIDS; BORONIC ACIDS; CEFOXITIN; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CLAVULANIC ACID; DISK DIFFUSION ANTIMICROBIAL TESTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYME INDUCTION; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; SUBSTRATE SPECIFICITY;

AMPC BETA-LACTAMASES; BORONIC ACID; CEFEPIME; ENTEROBACTERIACEAE; ESBL;

EID: 84874424950     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: 10.11604/pamj.2013.14.28.1347     Document Type: Article

References (33)

1. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001; 14: 933-995. PubMed/Google Scholar
2. Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis. 2003; 36:S11-S23. PubMed/Google Scholar
3. Paterson DL, Bonomo RA. Extended spectrum β-lactamases: A clinical update. Clin Microbiol Rev. 2005; 18: 657-686. PubMed/Google Scholar
4. Philippon AG, Arlet, Jacoby GA. Plasmid determined AmpC type beta-lactamases. Antimicrob Agents Chemother. 2002; 46:1-11. PubMed/Google Scholar
5. Rodriguez-Martinez JM, Pascual A, Garcia I, Martinez-Martinez L. Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumonia producing AmpC-type β-lactamase. J Antimicrob Chemother. 2003; 52: 703-706. PubMed/Google Scholar
6. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe KW. Epidemiology and clinical features of blood stream infections caused by AmpC-type beta-lactamase producing Klebsiella pneumonia. Antimicrob Agents Chemother. 2004; 48: 3720-3728. PubMed/Google Scholar
7. CLSI. 200 Performance standards for antimicrobial susceptibility testing. CLSI approved standard M100-S1 Clinical and Laboratory Standards Institute, Wayne, PA. PubMed/Google Scholar
8. Black JA, Thomson KS, Pitout JD. Use of beta-lactamase inhibitors in disk tests to detect plasmid mediated ampC beta-lactamases. J Clin Microbiol. 2004; 42:2203-2206. PubMed/Google Scholar
9. Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-mediated ampC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases. J Clin Microbiol. 2005; 43:3110-3113. PubMed/Google Scholar
10. Yagi T, Wachino J, Kurokawa H, Suzuki S, Yamane K, Doi Y, Shibata N, Kato H, Shibayama K, Arakawa Y. Practical methods using Boronic acid compounds for identification of class C beta-lactamase producing Klebsiella pneumonia and Escherichia coli. J Clin Microbiol. 2005; 43: 2551-2558. PubMed/Google Scholar
11. Nasim K, Elsayed S, Pitout JD, Conly J, Church DL, Gregson DB. New method for laboratory detection of AmpC beta-lactamases in Escherichia coli and Klebsiella pneumonia. J Clin Microbiol. 2004;42:4799-4802. PubMed/Google Scholar
12. Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumonia, and Proteus mirabilis isolates at a Veterans medical center. J Clin Microbiol. 2000; 38: 1791-1796. PubMed/Google Scholar
13. Manchanda V, Singh NP. Occurrence and detection of AmpC beta-lactamases among gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur hospital, Delhi, India. J Antimicrob Chemother. 2003; 51:415-418. PubMed/Google Scholar
14. Shahid M, Malik A, Agarwal M, Singhal S. Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inoculation method and modified three-dimensional extract test: Comparison with conventional three-dimensional extract test. J Antimicrob Chemother. 2004; 54:684-687. PubMed/Google Scholar
15. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R, Rattan A. Evaluation of methods for AmpC beta-lactamase in Gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol. 2005; 23: 120-124. PubMed/Google Scholar
16. Coudron PE. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp, Escherichia coli, and Proteus mirabilis. J Clin Microbiol. 2005; 43:4163-4167. PubMed/Google Scholar
17. Beesley T, Gascoyne N, Knott-Hunziker V, Petursson S, Waley SG, Jaurin B, Grundstrom T. The inhibition of class C beta-lactamases by Boronic acids. Biochem J. 1983; 209: 229-233. PubMed/Google Scholar
18. Tondi D, Calo S, Shoichet BK, Costi MP. Structural study of phenyl boronic acid derivatives as AmpC beta-lactamase inhibitors. Bioorg Med Chem Lett. 2010; 20:3416-3419. PubMed/Google Scholar
19. Song W, Bae IK, Lee Y, Lee C, Lee SH, Jeong SH. Detection of Extended-spectrum beta-lactamases by using Boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol. 2007; 45:1180-1184. PubMed/Google Scholar
20. Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH, Lee KM. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp, Salmonella spp and Proteus mirabilis. Diagn Microbiol Infect Dis. 2007; 57: 315-318. PubMed/Google Scholar
21. Jeong SH, Song W, Park MJ, Kim JS, Kim HS, Bae IK, Lee KM. Boronic acid disk tests for identification of extended-spectrum beta-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC beta-lactamases. Int J Antimicrob Agents. 2008; 31: 467-471. PubMed/Google Scholar
22. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Win WC. In: The Enterobacteriaceae: color atlas and textbook of diagnostic microbiology. 5th ed. JB Lippincott Co: Philadelphia. 2006; 211-302. PubMed/Google Scholar
23. Clinical and Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Eighteenth Informational Supplement. 2008. USA. Google Scholar
24. Thomson KS. Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis. 2001; 7: 333-336. PubMed/Google Scholar
25. Shoorashetty RM, Nagarathnamma T, Prathibha J. Comparison of the boronic acid disk potentiation test and cefepime-clavulanic acid method for the detection of ESBL among AmpC-producing Enterobacteriaceae. Indian J Med Microbiol. 2011; 29:297-301. PubMed/Google Scholar
26. Rudresh SM, Nagarathnamma T. Two simple modifications of modified three-dimensional extract test for detection of AmpC beta-lactamases among the members of family Enterobacteriaceae. Chronicles of young Scientists. 2001; 2(1): 42-46. PubMed/Google Scholar
27. Sturenburg E, Sobottka I, Noor D, Laufs R, Mack D. Evaluation of a new cefepime-CA ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection. J Antimicrob Chemother. 2004; 54:134-138. PubMed/Google Scholar
28. Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev. 2009; 22: 161-182. PubMed/Google Scholar
29. Liu PYF, Gur D, Hall LMC, Livermore DM. Survey of the prevalence of beta-lactamases amongst 1000 Gram-negative bacilli isolated consecutively at the Royal London Hospital. J Antimicrob Chemother. 1992; 30: 429-447. PubMed/Google Scholar
30. Manchanda V, Singh NP, Shamweel A, Eideh HK, Thukral SS. Molecular epidemiology of clinical isolates of AmpC producing Klebsiella pneumonia. Indian J Med Microbiol. 2006; 24: 177-181. PubMed/Google Scholar
31. Wong-Beringer A. Therapeutic challenges associated with extended-spectrum Beta-lactamase-producing Escherichia coli and Klebsiella pneumonia. Pharmacotherapy. 2001; 21: 583-592. PubMed/Google Scholar
32. Babypadmini S, Appalaraju B. Extended spectrum beta lactamase in urinary isolates of Escherichia coli and Klebsiella pneumonia -prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol. 2004; 22: 172-174. PubMed/Google Scholar
33. Shukla I, Tiwari R, Agrawal M. Prevalence of extended spectrum beta-lactamases producing Klebsiella pneumonia in a tertiary care hospital. Indian J Med Microbiol. 2004; 22: 87-91. PubMed/Google Scholar